Mesterolone (Proviron) Oral Tablet
This entry covers the oral tablet form of mesterolone, a 1-methyl dihydrotestosterone derivative marketed as Proviron. It is an orally active, non-17-alkylated androgen used clinically for hypogonadism and low libido, and non-medically as an anti-estrogenic ancillary and free-testosterone booster rather than a mass-building steroid.
01 Overview
Mesterolone is a 1-methylated DHT derivative that is orally active without 17-alpha-alkylation, giving it a low hepatic burden. Clinically it has been used for androgen deficiency, low libido and some cases of male infertility. It does not aromatise and binds strongly to sex-hormone-binding globulin (SHBG), which can raise free levels of co-administered androgens.
In physique circles the oral tablet is used less for muscle gain and more as an ancillary: to firm up physique, support libido during cycles, and act mildly against estrogenic effects. This entry emphasises the oral tablet pharmacology and dosing.
02 Mechanism
Androgen-receptor agonist; a 1-methyl-5-alpha DHT derivative that resists aromatisation and binds SHBG, indirectly raising free testosterone. Orally active without 17-alkylation.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Ancillary | 25–100 mg/day | Oral | Non-medical ancillary use alongside other compounds. |
| Clinical | 25–75 mg/day | Oral | FDA/EU range for androgen deficiency, often 25 mg 1-3x daily. |
Ester comparison
| Ester | Half-life | Injection freq. | Testosterone by mass |
|---|
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Improved libido and moodEffective for low libido and androgen-deficiency symptoms. | restored sexual function in hypogonadism | Clinical | |
| Raised free testosteroneSHBG binding can increase the free fraction of other androgens. | via SHBG binding | Observational | |
| Mild anti-estrogenic effectMay slightly reduce estrogenic effects during a cycle. | modest | Observational |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Androgenic effectsAcne, oily skin and possible hair-loss acceleration in predisposed users. | Mild | Dose-related | Clinical | |
| HPTA suppressionSome suppression of endogenous testosterone, generally modest at typical doses. | Mild | Milder than most orals | Clinical |